Association between VEGF polymorphisms and homocysteine levels in patients with ischemic stroke and silent brain infarction

Stroke

Volumn 42, Issue 9, 2011, Pages 2393-2402

  Kim, Ok Joon ^a   Hong, Seung Ho ^b   Oh, Seung Hun ^a   Kim, Tae Gon ^a   Min, Kyung Tae ^a   Oh, Doyeun ^a   Kim, Nam Keun ^a  

^a CHA University   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

polymorphism; silent brain infarction; stroke; vascular endothelial growth factor

Indexed keywords

HOMOCYSTEINE; VASCULOTROPIN;

ADULT; ALLELE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN INFARCTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80052398368     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.607739     Document Type: Article

References (71)

1. World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: WHO; 2002. Available at: www.who.int/whr/2002/ en/. Accessed October 4, 2003.
2. Warlow CP. Epidemiology of stroke. Lancet. 1998;352:SIII1-SIII4.
3. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001;32:280-299.
4. Korea National Statistical Office. Change in leading causes of death (1999-2009). 2009. Available at: kosis.kr/ups3/service/ch-file-down. jsp?PUBCODE-YD&FILE-NAME-/ups3/upload/101/YD/VD0005. xls&SEQ-8. Accessed June 26, 2011.
5. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman MM. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2002;33:21-25.
6. Kase CS, Wolf PA, Chodosh EH, Zacker HB, Kelly-Hayes M, Kannel WB, et al. Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study. Stroke. 1989;20:850-852.
7. Malinow MR. Homocyst(e)ine and arterial occlusive disease. J Intern Med. 1994;236:603-617.
8. Durand P, Lussier-Cacan S, Blache D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB. 1997;11:1157-1168.
9. Duell PB, Malinow MR. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol. 1997;8:28-34.
10. Matsui T, Arai H, Yuzuriha T, Yao H, Miura H, Hashimoto S, et al. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke. 2001;32:1116-1119.
11. Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol. 2002;51:285-289.
12. Howard G, Wagenknecht LE, Cai J, Cooper L, Kraut MA, Toole JF. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke. 1998;29:913-917.
13. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke. 1997;28: 1932-1939.
14. Kwon HM, Kim BI, Lee SH, Choi SH, Oh BH, Yoon BW. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke. 2006;37:466-470.
15. La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F, Capella C. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features. Hum Pathol. 2003;34:18-27.
16. Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation. 1996;93:1493-1495.
17. Leung DW, Cachianes G. Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
18. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
19. Ogunshola OO, Stewart WB, Mihalcik V, Solli T, Madri JA, Ment LR. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res. 2000;119:139-153.
20. Kovacs Z, Ikezaki K, Samoto K, Inamura T, Fukui M. VEGF and Flt. Expression time kinetics in rat brain infarct. Stroke. 1996;27:1865-1872.
21. Hayashi T, Abe K, Suzuki H, Itoyama Y. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke. 1997;28:2039-2044.
22. Lennmyr F, Ata KA, Funa K, Olsson Y, Terent A. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol. 1998;57:874-882.
23. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5′UTR regions of the human vascular endothelial growth factor gene. Hum Immunol. 1999;60: 1245-1249.
24. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 2000;12:1232-1235.
25. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000;37:443-448.
26. Lee HH, Hong SH, Shin SJ, Ko JJ, Oh D, Kim NK. Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion. Fertil Steril. 2010;93:1244-1247.
27. Papazoglou D, Galazios G, Koukourakis MI, Panagopoulos I, Kontomanolis EN, Papatheodorou K, et al. Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod. 2004;10: 321-324.
28. Del Bo R, Scarlato M, Ghezzi S, Martinelli F, Boneschi M, Fenoglio C, et al. Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol. 2005;57:373-380.
29. Park HM, Hong SH, Kim JW, Oh D, Hwang SG, An HJ, et al. Genderspecific association of the VEGF-2578C A polymorphism in Korean patients with colon cancer. Anticancer Res. 2007;27:2535-2539.
30. Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res. 2005;11: 3647-3653.
31. Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C-T) gene and colon cancer in Korea. Anticancer Res. 2008;28:1271-1276.
32. Bae SJ, Ahn DH, Hong SP, Kang H, Hwang SG, Oh D, et al. Genderspecific association between polymorphism of vascular endothelial growth factor (VEGF 936C-T) gene and patients with stomach cancer. Yonsei Med J. 2008;49:783-791.
33. Yang JP, Liu HJ, Wang ZL, Cheng SM, Cheng X, Xu GL, et al. The dose-effectiveness of intranasal VEGF in treatment of experimental stroke. Neurosci Lett. 2009;461:212-216.
34. Zhang W, Sun K, Zhen Y, Wang D. Wang Y, Chen J, et al. VEGF receptor-2 variants are associated with susceptibility to stroke and recurrence. Stroke. 2009;40:2720-2726.
35. Welch GN, Upchurch GJR, Loscalzo J. Hyperhomocyst(e)inemia and atherothrombosis. Ann NY Acad Sci. 1997;811:48-58.
36. Nagai Y, Tasaki H, Takatsu H, Nihei S, Yamashita K, Nakashima Y. Homocysteine inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Commun. 2001;281:726-731.
37. Guerzoni AR, Biselli PM, Godoy MF, Souza DR, Haddad R, Eberlin MN, et al. Homocysteine and MTHFR and VEGF gene polymorphisms: impact on coronary artery disease. Arq Bras Cardiol. 2009;92:249-254.
38. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
39. Lee BC, Roh JK. International experience in stroke registries: Korean Stroke Registry. Am J Prev Med. 2006;31:S243-S245.
40. Kim NK, Choi BO, Jung WS, Choi YJ, Choi KG. Hyperhomocysteinemia as an independent risk factor for silent brain infarction. Neurology. 2003;61:1595-1599.
41. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B. 1995;57:289-300.
42. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics. 1987;117:331-341.
43. Simmons M. Angiogenesis. Where do we stand now? Circulation. 2005; 111:1556-1566.
44. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease part I: angiogenic cytokines. Circulation. 2004;109: 2487-2491.
45. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol. 2000;156: 965-976.
46. Sun Y, Jin K, Xie L, Childs J, Mao XO, Mogvinova A, et al. VEGFinduced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111:1843-1851.
47. Verheul HMW, Jorna AS, Hoekman K, Broxterman HJ, Gebbink MF, Pinedo HM. Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood. 2000;96: 4216-4221.
48. Verheul HMW, Hoekman K, Lupu F, Broxterman HJ, Kakkar AK, Pinedo HM. High VEGF concentration and activation of coagulation pathway, including platelets, in aspirated fluids of soft tissue sarcomas. Clin Cancer Res. 2000;6:166-171.
49. Yang JP, Liu HJ, Liu XF. VEGF promotes angiogenesis and functional recovery in stroke rats. J Invest Surg. 2010;23:149-155.
50. Papavassiliou E, Gegate N, Proescholdt M, Heiss JD, Walbridge S, Edwards NA, et al. Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain. J Neurosci Res. 1997;49: 451-460.
51. Kubo M. Genetic risk factors of ischemic stroke identified by a genome-wide association study Brain Nerve. 2008;60:1339-1344.
52. Yamada Y, Fuku N, Tanaka M, Aoyagi Y, Sawabe M, Metoki N, et al. Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis. 2009;207:144-149.
53. Ding H, Wu B, Wang H, Lu Z, Yan J, Wang X, et al. A novel loss-offunction DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. Stroke. 2010;41:177-180.
54. Banerjee I, Gupta V, Ganesh S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J Hum Genet. 2007;52:205-219.
55. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocyst(e)ine and ischemic stroke due to large-and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke. 2003;31:1069-1075.
56. Markus HS, Ali S, Swaminathan R, Sankaralingam A, Mollo J, Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke. 1997; 28:1739-1743.
57. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L. Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol. 2002;249:1391-1397.
58. Roman GC, Erkinjuntti T, Wallin A, Oantoni L, Chui HC. Subcortical ischemic vascular dementia. Lancet Neurol. 2002;1:426-436.
59. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Saewada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2:89-98.
60. Choi BO, Kim NK, Kim SH, Kang MS, Lee S, Ahn JY, et al. Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb Res. 2003;111: 39-44.
61. Morita H, Kurihara H, Tsubaki S, Sugiyama T, Hamada C, Kurihara Y, et al. Methylene-tetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler Thromb Vasc Biol. 1998;18: 1465-1469.
62. Yoo JH, Choi GD, Kang SS. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler Thromb Vasc Biol. 2000;20:1921-1925.
63. Makin AJ, Chung NAY, Silverman SH, Lip GY. Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis? Clin Sci. 2003;104:397-404.
64. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation. 1998;98: 2108-2116.
65. Roybal CN, Yang S, Sun CW, Hurtado D, Jagt DLV, Townes TM, et al. Homocysteine increases the expression of VEGF by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem. 2004;279:14844-14852.
66. Maeda M, Yamamoto I, Fujio Y, Azuma J. Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages. Biochim Biophys Acta. 2003;1623:41-46.
67. Mazure NM, Chen EY, Yeh P, Laderoute KR, Giaccia AJ. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res. 1996;56:3436-3440.
68. Shastry S, Tyagi N, Hayden MR, Tyagi SC. Proteomic analysis of homocysteine inhibition of microvascular endothelial cell angiogenesis. Cell Mol Biol. 2004;50:932-937.
69. Atta HM, El-Rehani MA, Raheim SA, Galal AMF. Lowering homocysteine decreases levels and expression of VEGF165 and endostatin. J Surg Res. 2008;146:202-210.
70. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wascher TC, Paulweber B, et al. A common 936C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer. 2003;106:468-471.
71. Scandurro AB, Beckman BS. Common proteins bind mRNAs encoding erythropoietin, tyrosine hydroxylase, and vascular endothelial growth factor. Biochem Biophys Res Commun. 1998;246:436-440.